Endocrine · Nov 16, 2026
Carotid plaque detection in patients with type 2 diabetes: development, interpretability, and limited transportability of a clinical model
By Liu X, Xu G, Wang XJ
Objective To develop and evaluate a parsimonious model for detecting prevalent carotid plaque in type 2 diabetes mellitus (T2DM), and to assess its interpretability, robustness, and transportability. Methods This retrospective cross-sectional study enrolled 2,035 hospitalized patients with T2DM, randomly assigned 70:30 to training and test sets. Bidirectional stepwise regression screened 39 candidate variables; stability was assessed by bootstrap resampling (1,000 replicates) and penalized regression. Performance was compared with random forest and XGBoost, and TreeSHAP was used for interpretability. Interaction terms, a non-medication model, and high-sensitivity thresholds were evaluated. The model was applied to an independent cohort of 3,191 health-screening individuals, with updating assessed by split-half validation. Results Eight predictors were retained. The test-set AUC was 0.827 (95% CI 0.791–0.862), versus 0.804 for random forest and 0.816 for XGBoost (P = 0.023 versus random forest). Only age and statin use were selected in 100% of bootstrap resamples. Removing statin use and GLP-1RA lowered the AUC to 0.787 (ΔAUC − 0.040, P < 0.001), retaining a history of coronary heart disease. No interaction term was significant (joint P = 0.511). In the external cohort, the AUC was 0.666 with marked miscalibration; updating left discrimination unchanged, and at 85% sensitivity, specificity was 33.4%. Conclusion An eight-variable logistic model using routinely available variables performed comparably to machine learning models for detecting prevalent carotid plaque in the development cohort. However, variable selection was unstable, and statin use was the strongest but indication-confounded correlate. External discrimination was moderate and did not improve after recalibration, indicating limited transportability. The model is best regarded as an exploratory candidate requiring further setting-specific validation, rather than one that may already aid in the detection of clinical cases.
doi.org/10.1007/s12020-026-04828-9Open accessPubMed 43037798Biomarkers